Big Pharma profiteering gone wild: $1,000-a-pill Hepatitis drug in USA sells for less than $10 in Egypt

sentinelblog

by J. D. Heyes, Natural News

The financial raping of America by Big Pharma has just achieved a new milestone with the impending launch of a Hepatitis C drug that costs $1,000 a pill. If you’ve ever wondered why U.S. health care is so unaffordable and inaccessible — and why health insurance costs are bankrupting businesses and municipalities across the nation — this is exactly why. The same drug that sells for $1,000 a pill in the USA — named “Sovaldi” — sells for just $10 in Egypt, or 1/100th the USA price.

Drug companies are, of course, granted FDA-enforced monopolies on the treatment of anything considered a “disease.” As such, drugs are pushed into the marketplace at monopoly prices. Because if you’re the CEO of Gilead Sciences, Inc., makers of the Sovaldi drug to be sold at $1,000 a pill, your job is to maximize revenues by any means…

View original post 46 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s